Now available FAVLYXA™

FAVLYXA™ (fluorouracil) is a nucleoside metabolic inhibitor indicated for the treatment of patients with:

• Adenocarcinoma of the Colon and Rectum
• Adenocarcinoma of the Breast
• Gastric Adenocarcinoma
• Pancreatic Adenocarcinoma

Please see full prescribing information here.